Gamida Cell (GMDA) Short Interest Ratio & Short Volume

Short interest is the volume of Gamida Cell shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 10,960,000 shares of GMDA short. Learn More on Gamida Cell's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMDA shares currently have a short interest ratio of 4.0. Learn More on Gamida Cell's short interest ratio.

Gamida Cell saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 10,960,000 shares, an increase of 9.8% from the previous total of 9,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Gamida Cell: Avalon GloboCare Corp. (2.84%), TC Biopharm (Holdings) Plc (34.94%), Scinai Immunotherapeutics Ltd. (1.20%), TRACON Pharmaceuticals, Inc. (1.16%), Acorda Therapeutics, Inc. (0.66%), Finch Therapeutics Group, Inc. (1.96%), Palisade Bio, Inc. (4.12%), Fresh Tracks Therapeutics, Inc. (0.17%), Creative Medical Technology Holdings, Inc. (1.76%), Titan Pharmaceuticals, Inc. (1.72%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks.

Short selling GMDA is an investing strategy that aims to generate trading profit from Gamida Cell as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Gamida Cell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GMDA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMDA, twice per month. The most recent reporting period available is March, 15 2024.